ClinConnect ClinConnect Logo
Search / Trial NCT06309693

Postoperative Pain Management Following Robotic Assisted Sacrocolpopexy

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Mar 7, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Minimally Invasive Sacrocolpopexy Quadratus Lumborum Block Postoperative Pain Pelvic Organ Prolapse

ClinConnect Summary

This clinical trial is focused on managing pain after surgery for women with a condition called pelvic organ prolapse. Specifically, it aims to compare two methods of pain relief: the Enhanced Recovery After Surgery (ERAS) protocol, which is a standard approach to help patients heal better after surgery, and a specific nerve block called the quadratus lumborum (QL) block, which may reduce pain more effectively. The researchers want to find out if using the QL block can lead to lower pain scores after surgery and reduce the need for opioid medications, which are often prescribed for pain but can have unwanted side effects.

To participate in this trial, women must be at least 18 years old and undergoing robotic-assisted surgery for pelvic organ prolapse, possibly along with a hysterectomy (removal of the uterus). Participants should be fluent in English and able to give their consent to join the study. Those who take part can expect to be randomly assigned to one of the two pain management methods and will help researchers understand which approach works better for reducing pain after surgery. This is an important study aimed at improving postoperative care for women.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Women undergoing robotic-assisted sacrocolpopexy with concurrent robotic assisted supracervical or total laparoscopic hysterectomy or robotic assisted sacrocolpopexy after previous hysterectomy
  • 2. Age 18 years old or greater
  • 3. Fluency and literacy in English
  • 4. Capacity to provide consent
  • Exclusion Criteria:
  • 1. Lack fluency and literacy in English

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported